Your feedback is needed on our work groups and subject areas ...

We’re reviewing some of our IDDI Workstream activity, and we need you to help us shape the future agenda. For example, some questions of particular interest are:

What are the key challenges that you would like to see addressed by PVRI’s work groups?
What are your key priorities in Clinical Trial Design and New Modalities & Technologies?
What are the key blockers in trial design for emerging biopharma? Is clinical trial design ‘a done deal’ for big pharma?
What do we need to do about AI?
What’s good about the IDDI Workstreams, and where could we improve?

Your views matter, so please help us by sharing your thoughts using the feedback form below.

IDDI Workstream feedback form

Thank you for taking the time to complete our feedback form. Please answer any questions that are relevant and feel free to add your own comments.

Your name

Your email

What are the key challenges and emerging issues in PH that our IDDI Workstreams should be addressing?

What should be the key focus of the Clinical Trial Design Workstream?

What should be the key focus of the New Modalities & Technologies Workstream?

Any other comments?

Thank you for sharing your thoughts. Further discussions will take place at our Drug Discovery & Development Symposium in June, after which we will feed back to our membership. Watch this space!

Want to be part of something special?

All PVRI members are welcome to join an IDDI Workstream or a Task Force.

Join